Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Peptide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110194724B introduces diphenylmethane carriers for peptide synthesis, offering high purity, simplified extraction, and scalable manufacturing for reliable pharmaceutical intermediate supply.
Novel route avoids DKP impurities, offering high purity and yield for cost-effective pharmaceutical manufacturing and scalable supply chains.
Novel MOF-Cu catalyzed Ugi reaction for isoindolinone derivatives. Efficient, scalable, and cost-effective synthesis for pharma and agrochemical applications.
Patent CN1712399B details a novel hybrid synthesis of paclitaxel-MDP conjugates improving solubility and efficacy. Discover cost-effective manufacturing strategies for advanced API intermediates.
Solve supply chain risks for (2S,4R)-2-amino-4-methylnonanoic acid with this 8-step, high-yield synthesis. Achieve >99% optical purity at scale. Contact us for CDMO solutions.
Discover how visible light-driven catalysis enables 80-90% yields with 90-99% ee for chiral alpha-unnatural amino acids, eliminating costly chiral resolution steps in drug development.
Discover how visible light-driven copper catalysis eliminates chiral resolution steps, achieves 90-99% ee, and reduces production costs for non-natural amino acid derivatives in pharmaceutical synthesis.
Struggling with low yields in tyrosine serine pseudo-dipeptide synthesis? New green process achieves 98.5% purity & <0.2% impurities. Find reliable API suppliers now.
Solve ilomastat synthesis challenges with new low-cost, high-yield methods. Discover reliable suppliers for pharmaceutical intermediates with 98% purity.
Overcome low yields and high costs in N-Boc-N-Methyl-2-Amino-4,4-Dimethylpentanoic acid production. Discover emerging 3-step synthesis trends and find reliable suppliers for pharmaceutical intermediates.